Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125792013 | 12579201 | 3 | F | 201404 | 20160817 | 20160721 | 20160823 | EXP | DK-PFIZER INC-2016350692 | PFIZER | ANDERSEN, NB. BILATERAL AVASCULAR NECROSIS OF THE FEMORAL HEAD FOLLOWING TREATMENT OF EWING^S SARCOMA. ACTA ONCOLOGICA. 2016;55(6):792-795 | 28.00 | YR | M | Y | 0.00000 | 20160823 | MD | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125792013 | 12579201 | 1 | PS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | 20 MG/M2, CYCLIC, D1-3 (6 CYCLES) | 50467 | 20 | MG/M**2 | |||||||||
| 125792013 | 12579201 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | 150 MG/M2, CYCLIC, D1-3 (6 CYCLES) | 0 | 150 | MG/M**2 | |||||||||
| 125792013 | 12579201 | 3 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | 1.5 MG/M2, CYCLIC, D1 (6 CYCLES) | 0 | 1.5 | MG/M**2 | |||||||||
| 125792013 | 12579201 | 4 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | 3 MG/M2, CYCLIC, DAYS 1-3 (6 CYCLES) | 0 | 3 | MG/M**2 | |||||||||
| 125792013 | 12579201 | 5 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | 2 CYCLES AS SINGLE AGENT OVER 14 DAYS | 0 | |||||||||||
| 125792013 | 12579201 | 6 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | 3 MG/M2, CYCLIC, D1-2 | 0 | 3 | MG/M**2 | |||||||||
| 125792013 | 12579201 | 7 | SS | ACTINOMYCIN D | DACTINOMYCIN | 1 | 0.75 MG/M2, CYCLIC, D1-2 (6 CYCLES) | 0 | .75 | MG/M**2 | |||||||||
| 125792013 | 12579201 | 8 | C | PREDNISOLONE. | PREDNISOLONE | 1 | CYCLIC | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125792013 | 12579201 | 1 | Ewing's sarcoma |
| 125792013 | 12579201 | 2 | Ewing's sarcoma |
| 125792013 | 12579201 | 3 | Ewing's sarcoma |
| 125792013 | 12579201 | 4 | Ewing's sarcoma |
| 125792013 | 12579201 | 7 | Ewing's sarcoma |
| 125792013 | 12579201 | 8 | Antiemetic supportive care |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125792013 | 12579201 | OT |
| 125792013 | 12579201 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125792013 | 12579201 | Osteonecrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |